Anver Khan, DO
Pain Medicine · Hagerstown, MDNPI 1992169486
Payments from drug & device makers
What this record shows
This record is dominated by grants: $3,000 of the $4,882 with a category attached, or 61.4%. Medtronic accounts for 80.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $3,185 and has fallen 93.3% since, to $213 in 2025.
Across 74 payments — averaging $65.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$358
- Nevro Corp.$210
- Bioness Inc$119
- Boston Scientific$87
- Saluda Medical Americas, Inc.$78
- plus $88 from 3 others
What the payments were for
- Grants$3,00061%
- Food & beverage$1,88239%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 39 | $3,942 |
| Abbott | 24 | $358 |
| Nevro Corp. | 2 | $210 |
| Bioness Inc | 1 | $119 |
| Boston Scientific | 1 | $87 |
| Saluda Medical Americas, Inc. | 2 | $78 |
| Pacira Pharmaceuticals Incorporated | 2 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Stimwave Technologies Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$3,000
- Senza$130
- INCEPTIV$121
- Stimrouter for pain$119
- INTELLIS ADAPTIVESTIM$117
How this compares
$4,882 in reported general payments places this provider in the 70th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 211 | $5,447 |
| Xtampza ErOxycodone Myristate | 14 | $5,050 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 161 | $3,401 |
| Gabapentin | 235 | $2,944 |
| Oxycodone Hcl | 101 | $2,355 |
| Duloxetine Hcl | 132 | $2,285 |
| Buprenorphine | 11 | $1,607 |
| Naloxone Hcl | 24 | $1,453 |
| Morphine Sulfate ErMorphine Sulfate | 59 | $1,436 |
| Tramadol Hcl | 202 | $1,345 |
| Pregabalin | 78 | $1,157 |
| Celecoxib | 26 | $733 |
| Baclofen | 53 | $680 |
| Tizanidine Hcl | 43 | $599 |
| Cyclobenzaprine Hcl | 82 | $459 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Hagerstown
- David JamisonHagerstown$13K
- Thomas LarkinHagerstown$5K
- Vipul MangalOxon Hill$764K
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Kunal SoodGermantown$70K
- Ali TurabiBethesda$47K
- Behnam JafarpourBaltimore$45K
- Eric FinkelsteinOwings Mills$37K
- Ankush JainBethesda$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.